David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INSY
2351
DELISTED
Insys Therapeutics, Inc.
INSY
| $1.2M | ﹤0.01% |
134,714
+4,189
| +3% | +$43.2K |
|
2352
Invitation Homes
INVH
$17.9B
| $1.2M | ﹤0.01% |
52,774
-24,776
| -32% | -$549K |
|
2353
CALL
State Street
STT
$53B
| $1.19M | ﹤0.01% |
12,500
| – | – |
|
|
BMTC
2354
DELISTED
Bryn Mawr Bank Corp
BMTC
| $1.19M | ﹤0.01% |
27,140
-2,881
| -10% | -$120K |
|
|
SMPLW
2355
DELISTED
The Simply Good Foods Company Warrant
SMPLW
| $1.19M | ﹤0.01% |
+500,000
| New | +$1.22M |
|
2356
FedEx
FDX
$79B
| $1.19M | ﹤0.01% |
5,260
-223,857
| -98% | -$47.7M |
|
|
ASCMA
2357
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| $1.19M | ﹤0.01% |
91,057
-159
| -0.2% | -$2.11K |
|
2358
Century Communities
CCS
$2B
| $1.18M | ﹤0.01% |
47,931
-7,152
| -13% | -$173K |
|
2359
Boise Cascade
BCC
$2.83B
| $1.18M | ﹤0.01% |
33,838
-7,899
| -19% | -$240K |
|
2360
Federal Realty Investment Trust
FRT
$10.2B
| $1.18M | ﹤0.01% |
9,510
-12,621
| -57% | -$1.62M |
|
2361
Sibanye-Stillwater
SBSW
$8.87B
| $1.18M | ﹤0.01% |
280,885
+255,268
| +996% | +$1.28M |
|
2362
Grupo Aval
AVAL
$6.58B
| $1.18M | ﹤0.01% |
131,566
+22,219
| +20% | +$196K |
|
2363
CALL
Alnylam Pharmaceuticals
ALNY
$32.1B
| $1.18M | ﹤0.01% |
10,000
| – | – |
|
2364
PUT
Markel Group
MKL
$22.4B
| $1.18M | ﹤0.01% |
1,100
| – | – |
|
|
FCE.A
2365
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $1.17M | ﹤0.01% |
45,994
-18,922
| -29% | -$463K |
|
|
CLR
2366
PUT
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $1.17M | ﹤0.01% |
30,300
| – | – |
|
|
AT
2367
DELISTED
Atlantic Power Corporation
AT
| $1.17M | ﹤0.01% |
477,091
+8,756
| +2% | +$21K |
|
|
BHR
2368
Braemar Hotels & Resorts
BHR
$141M
| $1.17M | ﹤0.01% |
124,156
-82,369
| -40% | -$808K |
|
2369
PennantPark Floating Rate Capital
PFLT
$736M
| $1.17M | ﹤0.01% |
80,677
+57,829
| +253% | +$824K |
|
2370
PUT
Incyte
INCY
$26.3B
| $1.17M | ﹤0.01% |
10,000
| – | – |
|
|
ICD
2371
DELISTED
Independence Contract Drilling, Inc.
ICD
| $1.17M | ﹤0.01% |
15,346
-310
| -2% | -$21.9K |
|
2372
Geospace Technologies
GEOS
$72.3M
| $1.16M | ﹤0.01% |
65,310
-4,626
| -7% | -$70.4K |
|
2373
McGrath RentCorp
MGRC
$2.8B
| $1.16M | ﹤0.01% |
26,555
-32,210
| -55% | -$1.23M |
|
2374
Vornado Realty Trust
VNO
$7.46B
| $1.15M | ﹤0.01% |
15,013
-525,537
| -97% | -$40.1M |
|
2375
National CineMedia
NCMI
$256M
| $1.15M | ﹤0.01% |
16,477
+10,410
| +172% | +$673K |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.